Literature DB >> 30392104

Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction.

Hideki Yano1,2, Shigeo Horinaka3, Manami Watahik3, Tomoko Watanabe3, Toshihiko Ishimitsu3.   

Abstract

Cobalt-chromium everolimus-eluting stent (CoCr EES) is associated with a lower rate of stent thrombosis even in patients with ST-elevation myocardial infarction (STEMI). However, the time-serial changes of endothelial coverage of the stent struts in the extremely early period have never been reported, especially in patients with STEMI. The aim of this study was to compare the vessel healing process between CoCr EES and cobalt-chromium bare metal stent (CoCr BMS) implantations using optical coherence tomography (OCT) in patients with STEMI. Sixty-three patients who had primary emergent percutaneous coronary intervention (PCI) with CoCr EES (42 patients) or CoCr BMS (21 patients) were enrolled in this study for 3 years. OCT was performed just after, 2 and 12 weeks after EES or BMS implantations. Time-serial changes in the neointimal coverage (NIC), the neointimal thickness, and malapposition of stent struts were evaluated. NIC of stent struts did not differ between CoCr EES (23.2%, 99.4%) and CoCr BMS (24.0%, 97.8%) at 2 weeks and 12 weeks after PCI, respectively. Thicknesses of the neointima on the stent strut was significantly thinner in CoCr EES (34.0 ± 13.8, 107.0 ± 32.4 µm) than in CoCr BMS (40.0 ± 14.6, 115.7 ± 33.8 µm) at 2 weeks and 12 weeks after PCI (p = 0.011, p = 0.008), respectively. The malapposition did not differ just after PCI, and was completely resolved at 12 weeks after PCI in both groups. Thrombus was significantly less in CoCr EES than in CoCr BMS at 2 weeks (19.0% vs 42.9%, p < 0.01), and decreased over time in both groups, but at 12 weeks, disappeared only in CoCr EES (CoCr EES: 0% vs. CoCr BMS: 4.8%, p = 0.56). This study demonstrated that NIC and apposition of the stent struts almost completed at 12 weeks after EES and BMS implantations, while the neointimal thickness on the stent struts were thinner in EES than in BMS. Moreover, thrombus was significantly less in EES than in BMS implantations 2 weeks after PCI, which may explain the lower rate of acute and subacute stent thrombosis of EES compared with BMS.

Entities:  

Keywords:  Apposition; Everolimus-eluting stent; Neointimal thickness; Optical coherence tomography; ST-elevation myocardial infarction; Stent strut coverage

Mesh:

Substances:

Year:  2018        PMID: 30392104     DOI: 10.1007/s00380-018-1287-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  47 in total

1.  Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention.

Authors:  Fabrizio Imola; Maria Teresa Mallus; Vito Ramazzotti; Alessandro Manzoli; Alessandro Pappalardo; Alessandro Di Giorgio; Mario Albertucci; Francesco Prati
Journal:  EuroIntervention       Date:  2010-11       Impact factor: 6.534

2.  The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography.

Authors:  Jun Tanigawa; Peter Barlis; Konstantinos Dimopoulos; Miles Dalby; Philip Moore; Carlo Di Mario
Journal:  Int J Cardiol       Date:  2008-09-04       Impact factor: 4.164

3.  A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).

Authors:  Byeong-Keuk Kim; Myeong-Ki Hong; Dong-Ho Shin; Chung-Mo Nam; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Tae-Soo Kang; Byoung-Eun Park; Woong-Chol Kang; Seung-Hwan Lee; Jung-Han Yoon; Bum-Kee Hong; Hyuck-Moon Kwon; Yangsoo Jang
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

4.  Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.

Authors:  A Kastrati; J Mehilli; J Dirschinger; F Dotzer; H Schühlen; F J Neumann; M Fleckenstein; C Pfafferott; M Seyfarth; A Schömig
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

5.  Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.

Authors:  Shuji Otsuki; Salvatore Brugaletta; Manel Sabaté; Yoshitaka Shiratori; Omar Gomez-Monterrosas; Giancarla Scalone; Sebastian Romero-Villafañe; Marco Hernández-Enríquez; Xavier Freixa; Victoria Martín-Yuste; Mónica Masotti
Journal:  Cardiovasc Revasc Med       Date:  2016-03-05

6.  Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.

Authors:  Kumaran Kolandaivelu; Rajesh Swaminathan; William J Gibson; Vijaya B Kolachalama; Kim-Lien Nguyen-Ehrenreich; Virginia L Giddings; Leslie Coleman; Gee K Wong; Elazer R Edelman
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

7.  Pathological mechanisms of fatal late coronary stent thrombosis in humans.

Authors:  Andrew Farb; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

8.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Authors:  Renu Virmani; Giulio Guagliumi; Andrew Farb; Giuseppe Musumeci; Niccolo Grieco; Teresio Motta; Laurian Mihalcsik; Maurizio Tespili; Orazio Valsecchi; Frank D Kolodgie
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690

9.  Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography.

Authors:  Hiroki Katoh; Junya Shite; Toshiro Shinke; Daisuke Matsumoto; Yusuke Tanino; Daisuke Ogasawara; Takahiro Sawada; Naoki Miyoshi; Hiroyuki Kawamori; Naoki Yoshino; Ken-ichi Hirata
Journal:  Circ J       Date:  2009-04-14       Impact factor: 2.993

10.  Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents.

Authors:  Byeong-Keuk Kim; Jung-Sun Kim; Junbeom Park; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.